Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro

Nina Schultz, Kristoffer Brännström, Elin Byman, Simon Moussaud, Henrietta M Nielsen, , Anders Olofsson, Malin Wennström

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Abstract

The population of brain pericytes, a cell type important for vessel stability and blood brain barrier function, has recently been shown altered in patients with Alzheimer's disease (AD). The underlying reason for this alteration is not fully understood, but progressive accumulation of the AD characteristic peptide amyloid-beta (Aβ) has been suggested as a potential culprit. In the current study, we show reduced number of hippocampal NG2+ pericytes and an association between NG2+ pericyte numbers and Aβ1-40 levels in AD patients. We further demonstrate, using in vitro studies, an aggregation-dependent impact of Aβ1-40 on human NG2+ pericytes. Fibril-EP Aβ1-40 exposure reduced pericyte viability and proliferation and increased caspase 3/7 activity. Monomer Aβ1-40 had quite the opposite effect: increased pericyte viability and proliferation and reduced caspase 3/7 activity. Oligomer-EP Aβ1-40 had no impact on either of the cellular events. Our findings add to the growing number of studies suggesting a significant impact on pericytes in the brains of AD patients and suggest different aggregation forms of Aβ1-40 as potential key regulators of the brain pericyte population size.

Original languageEnglish
Article numbere12728
JournalAging Cell
Volume17
DOIs
Publication statusPublished - 2018

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro'. Together they form a unique fingerprint.

Cite this